View Author
study disease dementia patient alzheimer apolipoprotein genotype atherosclerosi allele level stroke association apoe *4 group effect delirium population subject rotterdam mutation apoe genotype carrier score reference apoe *4 allele onset apolipoprotein e rotterdam study model table person carotid cholesterol artery family apolipoprotein e polymorphism rivastigmine control study population follow-up factor smoking apolipoprotein e genotype netherland genet result polymorphism population-based department diagnosis care unit serum apoe *4 carriers frequency estrogen analysis hdl cholesterol plaque baseline estrogen use van duijn cm duijn university protein education neurology mortality apoe genotypes participant alzheimer disease smoker hofman cam-icu difference carotid artery atherosclerosis onset alzheimer survival number van broeckhoven c lancet
10 Most Recent Publications
|
Sleep monitoring by actigraphy in short-stay ICU patients
(Article)
Kooi, A. van der Tulen, J.H.M. Eijk, M.M.J. van Weerd, A.W. de Munster, B.C. van Slooter, A.J.C. |
2013-04-01
|
|
Routine use of the confusion assessment method for the intensive care unit: A multicenter study
(Article)
Eijk, M.M. van Boogaard, M. van den Karakus, A. Klijn, I.A. Kuiper, M.A. Leeuw, F.E. de Man, T. de Mast, R.C. van der Osse, R.J. Rooij, S.E.J.A. de Spronk, P.E. Voort, P.H.J. van der Marum, R.J. van Gool, W.A. van Slooter, A.J.C. Benner, P. Eikelenboom, P. Honing, M.L. Hoven, B. van der Horn, J. Izaks, G.J. Kalf, A. |
2011-08-01
|
|
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial
(Article)
Eijk, M.M. van Roes, K.C. Slooter, A.J.C. Honing, M.L. Kuiper, M.A. Karakus, A. Jagt, M. van der Spronk, P.E. Gool, W.A. van Mast, R.C. van der Kesecioglu, J. |
2010-11-27
|
|
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trial
(Article)
Eijk, M.M. van Roes, K.C. Slooter, A.J.C. Honing, M.L. Kuiper, M.A. Karakus, A. Jagt, M. van der Spronk, P.E. Gool, W.A. van Mast, R.C. van der Kesecioglu, J. |
2010-01-01
|
|
Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study
(Article)
Rijn, M.J.E. van Slooter, A.J.C. Bos, M.J. Catarino, C.F.B.S. Koudstaal, P.J. Hofman, A. Breteler, M.M.B. Duijn, C.M. van |
2006-01-01
|
|
Apoplipoprotein E and longevity: the Rotterdam study
(Letter To Editor)
Slooter, A.J.C. Cruts, M. Broeckhoven, C. van Duijn, C.M. van Hofman, A. |
2001-09-01
|
|
The Cystatin C polymorphism is not associated with early-onset Alzheimer's disease.
(Article)
Roks, G. Cruts, M. Slooter, A.J.C. Dermaut, B. Hofman, A. Broeckhoven, C. van Duijn, C.M. van |
2001-01-01
|
|
Apolipoprotein E and Carotid Artery Atherosclerosis. The Rotterdam Study
(Article)
Slooter, A.J.C. Bots, M.L. Havekes, L.M. Sol, A.I. del Cruts, M. Grobbee, D.E. Hofman, A. Broeckhoven, C. van Duijn, C.M. van Witteman, J.C.M. |
2001-01-01
|
|
Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study
(Article)
Slooter, A.J.C. Bots, M.L. Havekes, L.M. Sol, A.I. del Cruts, M. Grobbee, D.E. Witteman, J.C.M. Duijn, C.M. van Broeckhoven, C. van Hofman, A. |
2001-01-01
|
|
Apolipoprotein E genotype and the progression of Alzheimer's disease: the Rotterdam Study
(Article)
Slooter, A.J.C. Houwing-Duistermaat, J.J. Harskamp, F. van Cruts, M. Broeckhoven, C. van Hofman, A. Duijn, C.M. van Stijnen, Th. Breteler, M.M.B. |
1999-05-26
|
